New Key Statistics Module, Z-Score and F-Score
NAS:RARE Key Ratios
Market Cap $ M | 3,591.36 |
Enterprise Value $ M | 3,065.63 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 12.90 |
Price/Sales | 7.27 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 434.00 |
EPS (TTM) $ | -8.33 |
Beneish M-Score | -2.2 |
10-y EBITDA Growth Rate % | -14.30 |
5-y EBITDA Growth Rate % | -16.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -5.65 |
EV-to-EBITDA | -5.94 |
PEG | -- |
Shares Outstanding M | 83.13 |
Net Margin (%) | -139.70 |
Operating Margin % | -131.08 |
Pre-tax Margin (%) | -140.12 |
Quick Ratio | 2.49 |
Current Ratio | 2.61 |
ROA % (ttm) | -43.52 |
ROE % (ttm) | -300.57 |
ROIC % (ttm) | -82.68 |
Dividend Yield % | -- |
Altman Z-Score | -1.95 |
RARE Number of Guru Trades
RARE Volume of Guru Trades
Gurus Latest Trades with NAS:RARE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RARE is held by these investors
Total 1
Ultragenyx Pharmaceutical Inc Insider Transactions
No Available Data
News about NAS:RARE
Total 0- 1